Your browser doesn't support javascript.
loading
Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency.
Storr, H L; Prasad, R; Temple, I K; Metherell, L A; Savage, M O; Walker, J M.
Affiliation
  • Storr HL; Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. h.l.storr@qmul.ac.uk.
  • Prasad R; Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
  • Temple IK; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Metherell LA; Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
  • Savage MO; Centre for Endocrinology, John Vane Science Centre, William Harvey Research Institute (WHRI), Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
  • Walker JM; Department of Paediatric Endocrinology, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
J Endocrinol Invest ; 38(4): 407-12, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25352235
ABSTRACT

PURPOSE:

The IGFALS gene encodes the acid-labile subunit (ALS) protein, which regulates circulating IGF-1. Human IGFALS mutations cause growth hormone insensitivity (GHI) associated with ALS, IGF-1 and IGFBP-3 deficiencies and mild to moderate postnatal growth impairment (height SDS -2 to -4). Prenatal growth impairment is not a recognised feature of this disorder, but heterozygous carriers may show an intermediate phenotype.

METHODS:

We report a family of five subjects, including three children born small for gestational age, who were investigated for IGFALS gene mutations.

RESULTS:

The proband, an 8.7 years female with pre- and postnatal growth failure (BW SDS -3.04, Ht SDS -3.86) and biochemical features of GHI, had a homozygous mutation of IGFALS, c.401T>A; p.L134Q. Her 6.1 years brother (BW SDS -2.11, Ht SDS -2.0) had the same homozygous IGFALS mutation. Both parents [adult height SDS -1.76 (father) and -1.82 (mother)] and her 2.7 years sister (BW SDS -2.60, Ht SDS -2.04) were heterozygous for the IGFALS mutation.

CONCLUSION:

Significant phenotypic heterogeneity was observed between family members, in particular varying degrees of prenatal growth retardation were present in the three siblings, which may have contributed to the variation in the postnatal growth phenotype.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Infant, Small for Gestational Age / Glycoproteins / Carrier Proteins / Laron Syndrome / Growth Disorders Limits: Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Endocrinol Invest Year: 2015 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Infant, Small for Gestational Age / Glycoproteins / Carrier Proteins / Laron Syndrome / Growth Disorders Limits: Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Endocrinol Invest Year: 2015 Document type: Article Affiliation country: Reino Unido